Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
small decrease » small increased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
small decrease » small increased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Expected marginal mean QoL scores for two age cohorts over 2016–2024 in Gauteng, South Africa.
Published 2025Subjects: -
18
-
19
-
20